Review of Mycobacterium avium subsp. paratuberculosis antigen candidates with diagnostic potential

Heidi Mikkelsen1, Claus Aagaard, Søren Saxmose Nielsen

  • 1Adaptive Immunology and Parasitology, National Veterinary Institute, Technical University of Denmark, Bülowsvej 27, 1790 Copenhagen, Denmark.

Insights

Early diagnosis of Mycobacterium avium subsp. paratuberculosis (MAP) infection in ruminants is crucial. This review highlights diagnostic antigen candidates for cell-mediated immune (CMI) responses, essential for early detection before antibody development.

Area of Science:

  • Veterinary Immunology
  • Bacteriology
  • Diagnostic Microbiology

Background:

  • Mycobacterium avium subsp. paratuberculosis (MAP) causes latent infections in ruminants, with current diagnostics often detecting disease years after infection.
  • Antibody and fecal culture methods for MAP lack early detection capabilities.
  • Cell-mediated immune (CMI) responses offer a potential avenue for early MAP diagnosis.

Purpose of the Study:

  • To systematically review diagnostic MAP antigen candidates, focusing on those evaluated for CMI responses.
  • To identify promising antigens for developing early diagnostic tools for MAP infections.
  • To critically assess strategies for evaluating novel MAP antigen candidates.

Main Methods:

  • Systematic literature review of 115 different MAP antigens.
  • Categorization of antigens into CMI, secreted, cell wall/membrane, lipoprotein, heat shock, and hypothetical groups.
  • Analysis of antigens tested for CMI responses in diagnostic assays.

Main Results:

  • A comprehensive overview of 115 MAP antigens was compiled, categorized into six groups.
  • Few described antigens have been evaluated for CMI-based diagnostic assays.
  • No definitive MAP antigen candidate for CMI-based diagnostics has been identified to date.

Conclusions:

  • Effective early diagnosis of MAP infection requires improved diagnostic antigens for CMI responses.
  • Further research is needed to identify and validate specific MAP antigens for CMI-based diagnostics.
  • Future studies should include appropriate sample sizes for robust evaluation of antigen candidates.